web analytics
4.7 C
Munich
Tuesday, November 29, 2022

The Inside Scoop on Solei Systems Inc (OTCMKTS: SOLI)

Solei Systems Inc (OTCMKTS: SOLI) started off 2019 with a bang making a huge run from pennies to $1.30 per share. Along the way the stock attracted a significant shareholder base many of whom are still holding on.

SOLI recently reversed off $0.13 lows and has been trending to the upside; this comes as a welcome reversal after many months of decline. There is plenty to get excited about on SOLI; its subsidiary CareClix is an emerging player in the booming telemedicine space and recently expanded its operations into Chile.

Solei Systems Inc (OTCMKTS: SOLI) is a fully reporting, fully audited public holding company in the health and wellness field with its primary focus on telemedicine. Currently Solei Systems, Inc is comprised of two wholly-owned subsidiaries: CareClix, Inc. and Clinical & Herbal Innovations, Inc. CareClix is a leading telemedicine solutions firm that provides software applications and a multispecialty medical network to a wide variety of health care services stakeholders. CareClix’s suite of services is revolutionizing the way hospitals, doctors, and clinical care providers can interact with an increasing number of patients. Clinical and Herbal Innovations Inc. a company responsible for the development and sales of a US Patented multispectrum vascular supplement which may have promising implications for cardiovascular wellness.

SOLI subsidiary CareClix is a leading telemedicine solutions firm that provides software applications and a multispecialty medical network to a wide variety of health care services stakeholders. CareClix’s suite of services is revolutionizing the way hospitals, doctors, and clinical care providers can interact with an increasing number of patients.

CareClix specializes in empowering medical providers through robust telemedicine software and access to ts extensive US physician and medical specialists’ network. Working with MC2 SALUD’s existing Chilean medical provider network for primary and specialists care visits, CareClix Chile offers significant potential to improve the population’s access to quality treatment in real-time. This strategic expansion into Chile can provide potentially thousands of Chilean medical professionals the power of CareClix telemedicine to improve care outcomes and patient satisfaction.

To Find out the inside Scoop on SOLI Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

SOLI

On Wednesday SOLI announced it is expanding its operations into Chile. “CareClix Chile” represents the company’s expansion into Chile through formal agreements with local companies designed to serve both public and private healthcare sectors in Chile. The company announced today the signing of a formal agreement with MC2 SALUD – HEALTHCARE ADVISERS. CareClix continues to expand through strategic partnerships with local partners and providers to expand within carefully selected markets.

Rafael Caviedes, co-founder and partner of MC2 SALUD – HEALTHCARE ADVISERS said, “I am thrilled to work with CareClix in Chile to introduce the next evolution of virtual healthcare to the population as a whole, i.e. creating access to quality specialist attention even in the country’s remotest regions. Telemedicine is the best way, in my view, to deliver the highest possible quality of virtual care.” Rafael’s partner and co-founder, Jonathan Callund, also commented, “CareClix has the proven track record and a Spanish-language solution needed. I expect to have a great impact on both the private and public healthcare sectors in Chile and possibly other markets in LatAm.”

Currently trading at a $27 million market valuation SOLI has $6.4 million in current liabilities and growing sales reporting $531k for the 3 months ended September 30, 2019. SOLI is an exciting story in small caps – SOLI subsidiary CareClix is an emerging player in the booming telemedicine space and recently expanded its operations into Chile. SOLI is a fraction over its all-time lows, has liquidity and a history of big moves, has a lot of eyes on it. We will be updating on SOLI when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with SOLI.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in SOLI either long or short and we have not been compensated for this article.

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.